Update of the patent litigation schedule in the United States for Plavix®
Update of the patent litigation schedule in the United States for Plavix® Paris, France – January 6, 2005 – The judge has signed a stipulation by the parties to an amended schedule. The date for submission of the pre-trial order has been set for March 4, 2005. About sanofi-aventis The sanofi-aventis Group is the world’s 3rd largest pharmaceutical company, ranking number 1 in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal